REGINA ROUSE: Open Payments
NPI 1487938825 · WEST COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$904 in 49 payments from 16 companies in 2025. Trend: 2023 $5,996 · 2024 $91 · 2025 $904
Food & beverage: $904
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $214 |
| ABBVIE INC. | 15 | $193 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $107 |
| Novartis Pharmaceuticals Corporation | 4 | $93 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Amgen Inc. | 2 | $33 |
| SCPHARMACEUTICALS INC. | 2 | $30 |
| Medtronic, Inc. | 2 | $30 |
| Abbott Laboratories | 2 | $30 |
| Merck Sharp & Dohme LLC | 1 | $25 |
Products named: Ozempic, VRAYLAR, Kerendia, LEQVIO, QULIPTA, Wegovy, Sunosi, REPATHA.
Industry payments across SC — which companies pay providers there.
